The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival. The once-popular DNA-testing site will also halt work on therapies it ...
Tempus AI said it agreed to pay $375 million in cash and $225 million in shares to acquire genetic testing company Ambry Genetics. Ambry conducts hereditary cancer screening and currently serves as ...
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...
CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...